John Goldman Fellows

Powerful new ideas in leukaemia research since 2015.

The John Goldman Fellowships were created to translate scientific advances in leukaemia research into clinical practice. 

Fellows reasearching AML

Acute Myeloid Leukaemia (AML) is a rare cancer of the blood that develops when the bone marrow produces underdeveloped white blood cells. Because it is acute, AML is quick to develop and requires immediate treatment. Read the research projects looking for new treatments and cures. 

Research Fellows investigating CLL and ALL

Chronic Lymphocytic Leukaemia (CLL) and Acute Lymphoblastic Leukaemia (ALL) are blood cancers caused by the bone marrow producing too many underdeveloped lymphocytes. CLL can progress slowly and rarely affects anyone under the age of 40. ALL is and acute leukaemia which occurs suddenly, progresses rapidly, and requires urgent treatment. Discover how John Goldman Fellows are researching new innovative treatments.

Fellows researching CML

Chronic myeloid leukaemia (CML) is one of four types of leukaemia. It is a cancer that affects white blood cells, and, because it is chronic rather than acute, CML tends to develop slowly over many years. Discover the John Goldman Fellowships looking for new cures.

Research fellows investigating other blood cancers

There are 137 different types of blood cancer and four main types of leukaemia, discover the research projects of our John Goldman Fellows search for new and innovative treatments and cures.